FDA recommends against prescribing Revatio to children for PAH

The U.S. Food and Drug Administration(FDA) is recommending that Revatio (sildenafil) not be prescribed to children (ages 1 through 17) for pulmonary arterial hypertension (PAH; high pressure in the blood vessels More...